Header cover image

Belgian Healthy high growth potential

Results

1

0 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1 companies

argenx

Market Cap: €38.4b

argenx SE, ein Biopharma-Unternehmen im kommerziellen Stadium, entwickelt verschiedene Therapien zur Behandlung von Autoimmunkrankheiten in den Vereinigten Staaten, Japan, China, den Niederlanden und international.

ARGX

€627.20

7D

-4.4%

1Y

31.8%